Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/8/2015
Financial-related Company News in Brief
1/8/2015
Hua Medicine Raises $25M to Facilitate Diabetes Drug R&D
1/8/2015
CFDA Lays Out Its Regulatory Plan for 2015
1/8/2015
CFDA to Fully Implement Electronic Drug Regulation in 2015
1/8/2015
Review of Recent Trends with Sino-Foreign Drug Licensing Deals
1/7/2015
Morgan Stanley: Pharma Sales Margin Needs to Improve in Emerging Marke...
1/7/2015
China Leads APAC's Type 2 Diabetes Drug Market Growth Before 2020
1/7/2015
Sihuan and Morgan Stanley to Acquire Nanjing Jiangbei People's Hospita...
1/6/2015
USFDA Issues Warning Letter to Chinese API Producer Novacyl Wuxi
1/6/2015
Jiangsu to Prioritize Reimbursement of Local Innovative Drugs through ...
1/6/2015
Chairman of PKU Pharma Taken Away for Insider Trading Investigation
1/6/2015
Tianjin SKF Becomes the First MNC to Open Online Store
1/5/2015
WuXi Launches Mobile App to Enable Chemistry-on-the-Go
1/5/2015
Recent Executive Moves
1/5/2015
NDRC: More Price Reform Measures to Come
1/5/2015
Sirnaomics and Xiangxue Pharma File IND for Anti-Fibrosis RNAi Therape...
1/4/2015
Recent CFDA Official Moves
1/1/2015
USTR Releases 2014 Report on China's WTO Compliance Highlighting Pharm...
12/31/2014
China Pharmaceutical Pricing Policy: Painful Reform, High Cost, But Pr...
12/31/2014
Guangzhou Unites Urban and Rural BMI Programs
12/30/2014
2014: The Top Ten Stories In China's Health Sector (External)
12/30/2014
Recent Executive Moves
12/30/2014
NDRC Outlines Roadmap to Contain Medical Costs
12/29/2014
CDE Enters Collaborative Framework Agreement with CPU and SPU
12/29/2014
NHFPC Highlights Primary Areas of Healthcare Reform in 2015
12/28/2014
Urgent Notice from Pharma China Team
12/26/2014
JD.com Granted Online Drug Sales Certification by CFDA
12/26/2014
CDE Seeks Comments on Draft Guidelines for Stability Studies of Biolog...
12/26/2014
CFDA Releases Its 2013 Annual Statistical Report
12/25/2014
Nanjing BioSciKin Licenses China Rights of Anti-CD3 Antibody from Ther...
Page:
396
/
720
Total number of articles:
21594
:
[First]
[<<]
[394]
[395]
[396]
[397]
[398]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit